Owners, management and financials
CVR: 42285722
DKK -92,000
Gross profit
Net result: DKK -61,449,000
DDC Mørk Holding ApS (15-19,99%), GHS III Midco B.V. (66,66-89,99%)
CVR · view owners
René Holmen Pedersen
Board: Niels Peder Nielsen (chair) and 3 members
CVR · view management
Active
Founded 7 April 2021
CVR · view overview
122 employees
Annual report 2025 · average
Director role ended: Rasmus Koch Nelund
CVR · 28/02/2025
View the full event history
Drug Development Consulting Holding ApS is a Danish company of the type Anpartsselskab based in Brøndby, founded in 2021. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of René Holmen Pedersen. The board consists of Niels Peder Nielsen (chair), Alejandra Maria Cristina Bonifacini Mørk, Rafael Natanek and Redmar Koene. The company is owned by DDC Mørk Holding ApS and GHS III Midco B.V.. According to the 2025 annual report, the company had an average of 122 employees. In 2025, the company reported a gross profit of DKK -92,000 and a net result of DKK -61,449,000 compared with DKK -13,302,000 the year before. Equity in the 2025 report amounted to DKK 32,586,000.
Selskabets formål er at eje kapitalandele i andre selskaber og anden i forbindelse hermed stående virksomhed, inklusiv, men ikke begrænset til, at yde management services til selskaber ejet fuldt eller delvist af selskabet.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | -92 t. | -61.4 mio. | 47.4 mio. | 32.6 mio. | 122 | |
| 202401/01/2024 – 31/12/2024 | -116 t. | -13.3 mio. | 79.2 mio. | 79.1 mio. | 146 | |
| 202301/01/2023 – 31/12/2023 | -53 t. | -9.4 mio. | 70.5 mio. | 70.5 mio. | 164 | |
| 202201/01/2022 – 31/12/2022 | -58 t. | -11.9 mio. | 72 mio. | 72 mio. | 184 |
Compared to 50.000 companies in Ikke-finansielle holdingselskaber
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreThe CVR number of Drug Development Consulting Holding ApS is 42285722.
Drug Development Consulting Holding ApS is owned by DDC Mørk Holding ApS and GHS III Midco B.V..
The management of Drug Development Consulting Holding ApS consists of René Holmen Pedersen.
The board of Drug Development Consulting Holding ApS consists of Niels Peder Nielsen, Alejandra Maria Cristina Bonifacini Mørk and Rafael Natanek, with Niels Peder Nielsen as chair.
In 2025, Drug Development Consulting Holding ApS reported a gross profit of DKK -92,000.
Drug Development Consulting Holding ApS had an average of 122 employees in the 2025 financial year according to the annual report.
Claim this page to add your logo and social links. Free to get started.
Address changed to Abildager 24, 2605 Brøndby (August 6, 2026).
Drug Development Consulting Holding ApS has published its annual report for 2025. Gross profit came to DKK -92,000, and the net result was DKK -61,449,000.
Drug Development Consulting Holding ApS has published its annual report for 2024. Gross profit came to DKK -116,000, and the net result was DKK -13,302,000.
As of February 28, 2025, Rasmus Koch Nelund has stepped down as director of Drug Development Consulting Holding ApS.
As of September 3, 2024, is registered as an owner of Drug Development Consulting Holding ApS with an ownership share of 66%.
Drug Development Consulting Holding ApS has published its annual report for 2023. Gross profit came to DKK -53,330, and the net result was DKK -9,376,330.
As of April 25, 2024, Mette Kirstine Agger has left the board of directors of Drug Development Consulting Holding ApS.
Drug Development Consulting Holding ApS has published its annual report for 2022. Gross profit came to DKK -58,000, and the net result was DKK -11,874,000.
As of June 1, 2023, René Holmen Pedersen is registered as director of Drug Development Consulting Holding ApS.
As of May 1, 2023, Rasmus Koch Nelund is registered as director of Drug Development Consulting Holding ApS.
As of April 30, 2023, Alejandra Maria Cristina Bonifacini Mørk has stepped down as director of Drug Development Consulting Holding ApS.
As of February 22, 2023, Niels Peder Nielsen has joined the board of directors of Drug Development Consulting Holding ApS.
As of February 22, 2023, Rafael Natanek has joined the board of directors of Drug Development Consulting Holding ApS.
As of February 21, 2023, Rafael Natanek has left the board of directors of Drug Development Consulting Holding ApS.
As of December 22, 2022, Alejandra Maria Cristina Bonifacini Mørk has joined the board of directors of Drug Development Consulting Holding ApS.
As of December 22, 2022, DDC Mørk Holding ApS is registered as an owner of Drug Development Consulting Holding ApS with an ownership share of 15%.
Drug Development Consulting Holding ApS has published its interim report for the period April 7, 2021 – December 31, 2021.
As of May 17, 2021, Mette Kirstine Agger has joined the board of directors of Drug Development Consulting Holding ApS.
As of May 17, 2021, Rafael Natanek has joined the board of directors of Drug Development Consulting Holding ApS.
As of May 17, 2021, Redmar Koene has joined the board of directors of Drug Development Consulting Holding ApS.
As of May 17, 2021, Alejandra Maria Cristina Bonifacini Mørk is registered as director of Drug Development Consulting Holding ApS.
As of May 17, 2021, Jasper Michiel van Gorp has stepped down as director of Drug Development Consulting Holding ApS.
As of April 7, 2021, EY Godkendt Revisionspartnerselskab has been appointed auditor of Drug Development Consulting Holding ApS.
As of April 7, 2021, Jasper Michiel van Gorp is registered as director of Drug Development Consulting Holding ApS.
Drug Development Consulting Holding ApS was founded on April 7, 2021.
Companies in the same industry and area
CVR 34885877
CVR 44752549
CVR 30556992
CVR 66310310
CVR 33063156
